n(4)-octadecyl-1-arabinofuranosylcytosine and Reperfusion Injury

n(4)-octadecyl-1-arabinofuranosylcytosine has been researched along with Reperfusion Injury in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Dzięgiel, P; Gomułkiewicz, A; Gziut, M; Merwid-Ląd, A; Nowak, B; Piasecki, T; Pieśniewska, M; Sozański, T; Szeląg, A; Szuba, A; Trocha, M; Wiśniewski, J	1

Other Studies

1 other study(ies) available for n(4)-octadecyl-1-arabinofuranosylcytosine and Reperfusion Injury

Article	Year
The impact of sitagliptin, inhibitor of dipeptidyl peptidase-4 (DPP-4), on the ADMA-DDAH-NO pathway in ischemic and reperfused rat livers. Advances in clinical and experimental medicine : official organ Wroclaw Medical University, 2018, Volume: 27, Issue:11 Topics: Amidohydrolases; Animals; Arginine; Cytarabine; Dipeptidyl-Peptidases and Tripeptidyl-Peptidases; Ischemia; Liver; Nitric Oxide; Protein-Arginine N-Methyltransferases; Rats; Reperfusion Injury; Sitagliptin Phosphate	2018

Article

Year

The impact of sitagliptin, inhibitor of dipeptidyl peptidase-4 (DPP-4), on the ADMA-DDAH-NO pathway in ischemic and reperfused rat livers.

Advances in clinical and experimental medicine : official organ Wroclaw Medical University, 2018, Volume: 27, Issue:11

Topics: Amidohydrolases; Animals; Arginine; Cytarabine; Dipeptidyl-Peptidases and Tripeptidyl-Peptidases; Ischemia; Liver; Nitric Oxide; Protein-Arginine N-Methyltransferases; Rats; Reperfusion Injury; Sitagliptin Phosphate

2018